These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1958029)

  • 1. Myelopeptides effect on longevity and immunological parameters in mice with congenital immunodeficiency.
    Mikhailova AA; Sorokin SV; Komponiec NA
    Ann Ist Super Sanita; 1991; 27(1):57-60. PubMed ID: 1958029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correction of immune response by myelopeptides in MRL/Mp-lpr/lpr mice with congenital autoimmune disorders].
    Petrov RV; Madzhidov UV; Sorokin SV; Mikhaĭlova AA
    Dokl Akad Nauk SSSR; 1986; 287(3):756-9. PubMed ID: 3698807
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelopeptides inhibit development of hereditary macrocytic anemia in W/Wv mice].
    Petrov RV; Kompaniets NA; Man'ko VM; Mikhaĭlova AA
    Dokl Akad Nauk SSSR; 1990; 310(1):247-9. PubMed ID: 2338049
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelopeptides: bone marrow regulatory mediators.
    Petrov RV; Mikhailova AA; Fonina LA
    Biosci Rep; 1995 Feb; 15(1):1-14. PubMed ID: 7647288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity.
    Petrov RV; Mikhailova AA; Fonina LA
    Biopolymers; 1997; 43(2):139-46. PubMed ID: 9216250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelopeptide correction of the differentiation of hematopoietic precursor cells in mice with experimental T-immunodeficiency].
    Rudneva TB; Osipova EIu; Makhaĭlova AA; Man'ko VM
    Biull Eksp Biol Med; 1989 Jun; 107(6):718-20. PubMed ID: 2790172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation by opioids in the immunostimulatory activity of myelopeptides.
    Zakharova LA; Belevskaya RG; Yanovskii OG
    Biomed Sci; 1990 Feb; 1(2):139-43. PubMed ID: 2102777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulating action of myelopeptides in severe closed experimental craniocerebral injury in rats].
    Lisianyĭ NI; Radzhievskiĭ AA; Zakharova LA
    Biull Eksp Biol Med; 1988 Mar; 105(3):310-1. PubMed ID: 3349170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals].
    Ianovskiĭ OG; Zakharova LA; Vasilenko AM
    Biull Eksp Biol Med; 1990 Jan; 109(1):55-7. PubMed ID: 2334799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and hematopoiesis. II. The ability of bone marrow cells from young and aged mice to cure and maintain cure in W/Wv.
    Boggs DR; Saxe DF; Boggs SS
    Transplantation; 1984 Mar; 37(3):300-6. PubMed ID: 6142551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL; Himeno K; Tsuru S; Nomoto K
    Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulating activity of myelopeptides: clinical trials.
    Petrov RV
    Ann N Y Acad Sci; 1993 Jun; 685():351-61. PubMed ID: 8363240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a bone marrow-associated Ly-6 determinant on the T cell population expanding in the lymph nodes of the autoimmune mouse strain MRL/Mp-lpr/lpr.
    Melino MR; Dumont FJ; Habbersett RC; Hansen TH
    J Immunol; 1983 Apr; 130(4):1843-7. PubMed ID: 6601141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.
    Eisenberg RA; Craven SY; Cohen PL
    J Immunol; 1987 Aug; 139(3):728-33. PubMed ID: 3474277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice.
    Christianson GJ; Blankenburg RL; Duffy TM; Panka D; Roths JB; Marshak-Rothstein A; Roopenian DC
    J Immunol; 1996 Jun; 156(12):4932-9. PubMed ID: 8648144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
    Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
    J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.